| 10098667
|
Design, synthesis, and evaluation of azapeptides as substrates and inhibitors for human rhinovirus 3C protease. |
Bioorg Med Chem Lett |
1999 |
Venkatraman S;Kong J;Nimkar S;Wang QM;Aube J;Hanzlik RP |
View
More |
| 10197964
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics. |
J Med Chem |
1999 |
Dragovich PS;Prins TJ;Zhou R;Fuhrman SA;Patick AK;Matthews DA;Ford CE;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 10197965
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. |
J Med Chem |
1999 |
Dragovich PS;Prins TJ;Zhou R;Webber SE;Marakovits JT;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Ford CE;Burke BJ;Rejto PA;Hendrickson TF;Tuntland T;Brown EL;Meador JW 3rd;Ferre RA;Harr JE;Kosa MB;Worland ST |
View
More |
| 10465543
|
Structure-based design of irreversible, tripeptidyl human rhinovirus 3C protease inhibitors containing N-methyl amino acids. |
Bioorg Med Chem Lett |
1999 |
Dragovich PS;Webber SE;Prins TJ;Zhou R;Marakovits JT;Tikhe JG;Fuhrman SA;Patick AK;Matthews DA;Ford CE;Brown EL;Binford SL;Meador JW 3rd;Ferre RA;Worland ST |
View
More |
| 10500114
|
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. |
Proc Natl Acad Sci U S A |
1999 |
Matthews DA;Dragovich PS;Webber SE;Fuhrman SA;Patick AK;Zalman LS;Hendrickson TF;Love RA;Prins TJ;Marakovits JT;Zhou R;Tikhe J;Ford CE;Meador JW;Ferre RA;Brown EL;Binford SL;Brothers MA;DeLisle DM;Worland ST |
View
More |
| 10506239
|
Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee. |
Pediatrics |
1999 |
Peter G;des Vignes-Kendrick M;Eickhoff TC;Fine A;Galvin V;Levine MM;Maldonado YA;Marcuse EK;Monath TP;Osborn JE;Plotkin S;Poland GA;Quinlisk MP;Smith DR;Sokol M;Soland DB;Whitley-Williams PN;Williamson DE;Breiman RF |
View
More |
| 10636240
|
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2000 |
Dragovich PS;Zhou R;Webber SE;Prins TJ;Kwok AK;Okano K;Fuhrman SA;Zalman LS;Maldonado FC;Brown EL;Meador JW 3rd;Patick AK;Ford CE;Brothers MA;Binford SL;Matthews DA;Ferre RA;Worland ST |
View
More |
| 10794684
|
Substituted benzamide inhibitors of human rhinovirus 3C protease: structure-based design, synthesis, and biological evaluation. |
J Med Chem |
2000 |
Reich SH;Johnson T;Wallace MB;Kephart SE;Fuhrman SA;Worland ST;Matthews DA;Hendrickson TF;Chan F;Meador J 3rd;Ferre RA;Brown EL;DeLisle DM;Patick AK;Binford SL;Ford CE |
View
More |
| 10921773
|
A novel method of aligning molecules by local surface shape similarity. |
J Comput Aided Mol Des |
2000 |
Cosgrove DA;Bayada DM;Johnson AP |
View
More |
| 11182317
|
A structurally biased combinatorial approach for discovering new anti-picornaviral compounds. |
Chem Biol |
2001 |
Tsang SK;Cheh J;Isaacs L;Joseph-McCarthy D;Choi SK;Pevear DC;Whitesides GM;Hogle JM |
View
More |
| 11750935
|
Treatment of picornavirus infections. |
Antiviral Res |
2002 |
Rotbart HA |
View
More |
| 11858991
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics. |
Bioorg Med Chem Lett |
2002 |
Dragovich PS;Prins TJ;Zhou R;Johnson TO;Brown EL;Maldonado FC;Fuhrman SA;Zalman LS;Patick AK;Matthews DA;Hou X;Meador JW;Ferre RA;Worland ST |
View
More |
| 12133721
|
Recent advances in the synthesis, design and selection of cysteine protease inhibitors. |
Curr Opin Chem Biol |
2002 |
Hernandez AA;Roush WR |
View
More |
| 12163617
|
Genetically stable picornavirus expression vectors with recombinant internal ribosomal entry sites. |
J Virol |
2002 |
Dufresne AT;Dobrikova EY;Schmidt S;Gromeier M |
View
More |
| 12746549
|
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. |
Science |
2003 |
Anand K;Ziebuhr J;Wadhwani P;Mesters JR;Hilgenfeld R |
View
More |
| 12838995
|
Drug Design--SMi Conference. 24-25 February 2003, London, UK. |
IDrugs |
2003 |
Mackonochie M |
View
More |
| 12944304
|
Dehydron: a structurally encoded signal for protein interaction. |
Biophys J |
2003 |
Fernandez A;Scott R |
View
More |
| 12951031
|
Isolation of a peptide inhibitor of human rhinovirus. |
Virology |
2003 |
Poritz MA;Malmstrom S;Schmitt A;Kim MK;Zharkikh L;Kamb A;Teng DH |
View
More |
| 1365526
|
Application of crystallography to the design of antiviral agents. |
Infect Agents Dis |
1992 |
Rossmann MG;McKinlay MA |
View
More |
| 13678411
|
Imidazo[1,2-b]pyridazines, novel nucleus with potent and broad spectrum activity against human picornaviruses: design, synthesis, and biological evaluation. |
J Med Chem |
2003 |
Hamdouchi C;Sanchez-Martinez C;Gruber J;Del Prado M;Lopez J;Rubio A;Heinz BA |
View
More |
| 14521419
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics. |
J Med Chem |
2003 |
Dragovich PS;Prins TJ;Zhou R;Johnson TO;Hua Y;Luu HT;Sakata SK;Brown EL;Maldonado FC;Tuntland T;Lee CA;Fuhrman SA;Zalman LS;Patick AK;Matthews DA;Wu EY;Guo M;Borer BC;Nayyar NK;Moran T;Chen L;Rejto PA;Rose PW;Guzman MC;Dovalsantos EZ;Lee S;McGee K;Mohajeri M;Liese A;Tao J;Kosa MB;Liu B;Batugo MR;Gleeson JP;Wu ZP;Liu J;Meador JW 3rd;Ferre RA |
View
More |
| 15080921
|
Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design. |
Bioorg Med Chem |
2004 |
Zhang XW;Yap YL |
View
More |
| 15320724
|
Inhibitors of 3C cysteine proteinases from Picornaviridae. |
Curr Top Med Chem |
2004 |
Lall MS;Jain RP;Vederas JC |
View
More |
| 15615532
|
Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target. |
J Med Chem |
2004 |
Klucik J;Xiao YD;Hammond PS;Harris R;Schmitt JD |
View
More |
| 15667141
|
LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. |
J Chem Inf Model |
2005 |
Wolber G;Langer T |
View
More |
| 15943481
|
BRUTUS: optimization of a grid-based similarity function for rigid-body molecular superposition. 1. Alignment and virtual screening applications. |
J Med Chem |
2005 |
Tervo AJ;Ronkko T;Nyronen TH;Poso A |
View
More |
| 1666824
|
A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program. |
Antiviral Res |
1991 |
Andries K;Dewindt B;Snoeks J;Willebrords R;Stokbroekx R;Lewi PJ |
View
More |
| 17305557
|
Human rhinovirus 3C protease as a potential target for the development of antiviral agents. |
Curr Protein Pept Sci |
2007 |
Wanga QM;Chen SH |
View
More |
| 18513807
|
A case for developing antiviral drugs against polio. |
Antiviral Res |
2008 |
Collett MS;Neyts J;Modlin JF |
View
More |
| 18583140
|
Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. |
Bioorg Med Chem |
2008 |
Kuo CJ;Shie JJ;Fang JM;Yen GR;Hsu JT;Liu HG;Tseng SN;Chang SC;Lee CY;Shih SR;Liang PH |
View
More |
| 18840470
|
New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3. |
Antiviral Res |
2009 |
Schmidtke M;Wutzler P;Zieger R;Riabova OB;Makarov VA |
View
More |
| 18852005
|
Deceptive imprinting and immune refocusing in vaccine design. |
Vaccine |
2008 |
Tobin GJ;Trujillo JD;Bushnell RV;Lin G;Chaudhuri AR;Long J;Barrera J;Pena L;Grubman MJ;Nara PL |
View
More |
| 19026659
|
In silico vaccine design based on molecular simulations of rhinovirus chimeras presenting HIV-1 gp41 epitopes. |
J Mol Biol |
2009 |
Lapelosa M;Gallicchio E;Arnold GF;Arnold E;Levy RM |
View
More |
| 19096995
|
In silico target fishing for rationalized ligand discovery exemplified on constituents of Ruta graveolens. |
Planta Med |
2009 |
Rollinger JM;Schuster D;Danzl B;Schwaiger S;Markt P;Schmidtke M;Gertsch J;Raduner S;Wolber G;Langer T;Stuppner H |
View
More |
| 20021285
|
Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors. |
Expert Opin Ther Pat |
2010 |
Wang HM;Liang PH |
View
More |
| 20138057
|
Antigenic characteristics of rhinovirus chimeras designed in silico for enhanced presentation of HIV-1 gp41 epitopes [corrected]. |
J Mol Biol |
2010 |
Lapelosa M;Arnold GF;Gallicchio E;Arnold E;Levy RM |
View
More |
| 21183345
|
Non-covalent inhibitors of rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2011 |
Baxter A;Chambers M;Edfeldt F;Edman K;Freeman A;Johansson C;King S;Morley A;Petersen J;Rawlins P;Spadola L;Thong B;Van de Poel H;Williams N |
View
More |
| 21215622
|
Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors. |
Bioorg Med Chem Lett |
2011 |
Wang H;Xiao J;Gao D;Zhang X;Yan H;Gong Z;Sun T;Li S |
View
More |
| 2154848
|
The microchip microbe hunters. |
Science |
1990 |
Alper J |
View
More |
| 21795339
|
Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. |
J Virol |
2011 |
Lu G;Qi J;Chen Z;Xu X;Gao F;Lin D;Qian W;Liu H;Jiang H;Yan J;Gao GF |
View
More |
| 22088306
|
Design, synthesis and in vitro evaluation of novel chroman-4-one, chroman, and 2H-chromene derivatives as human rhinovirus capsid-binding inhibitors. |
Bioorg Med Chem |
2011 |
Conti C;Proietti Monaco L;Desideri N |
View
More |
| 22926024
|
Tailored amino acid diversity for the evolution of antibody affinity. |
MAbs |
2012 |
Gonzalez-Munoz A;Bokma E;O'Shea D;Minton K;Strain M;Vousden K;Rossant C;Jermutus L;Minter R |
View
More |
| 23388726
|
3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses. |
J Virol |
2013 |
Tan J;George S;Kusov Y;Perbandt M;Anemuller S;Mesters JR;Norder H;Coutard B;Lacroix C;Leyssen P;Neyts J;Hilgenfeld R |
View
More |
| 23726345
|
Design, synthesis and biological evaluation of novel aminothiazoles as antiviral compounds acting against human rhinovirus. |
Bioorg Med Chem Lett |
2013 |
Decor A;Grand-Maitre C;Hucke O;O'Meara J;Kuhn C;Constantineau-Forget L;Brochu C;Malenfant E;Bertrand-Laperle M;Bordeleau J;Ghiro E;Pesant M;Fazal G;Gorys V;Little M;Boucher C;Bordeleau S;Turcotte P;Guo T;Garneau M;Spickler C;Gauthier A |
View
More |
| 24125888
|
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. |
Bioorg Med Chem Lett |
2013 |
Prior AM;Kim Y;Weerasekara S;Moroze M;Alliston KR;Uy RA;Groutas WC;Chang KO;Hua DH |
View
More |
| 24870364
|
A fragment-based method to discover irreversible covalent inhibitors of cysteine proteases. |
J Med Chem |
2014 |
Kathman SG;Xu Z;Statsyuk AV |
View
More |
| 24909291
|
Do we really need to keep redesigning beta2-agonists for the management of asthma? |
Curr Drug Deliv |
2015 |
Van Ly D;Oliver BG |
View
More |
| 24973816
|
Synthesis of new compounds with promising antiviral properties against group A and B Human Rhinoviruses. |
Bioorg Med Chem |
2014 |
Bernard AM;Cabiddu MG;De Montis S;Mura R;Pompei R |
View
More |
| 25259514
|
Synthesis and evaluation of 9-deoxy analogues of (-)-thysanone, an inhibitor of HRV 3C protease. |
Eur J Med Chem |
2014 |
Young Jeong J;Sperry J;Taylor JA;Brimble MA |
View
More |
| 25350699
|
Novel prodrug-like fusion toxin with protease-sensitive bioorthogonal PEGylation for tumor targeting. |
Bioconjug Chem |
2014 |
Stefan N;Zimmermann M;Simon M;Zangemeister-Wittke U;Pluckthun A |
View
More |
| 27265257
|
Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease. |
Bioorg Med Chem Lett |
2016 |
Kawatkar SP;Gagnon M;Hoesch V;Tiong-Yip C;Johnson K;Ek M;Nilsson E;Lister T;Olsson L;Patel J;Yu Q |
View
More |
| 28004945
|
Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIbeta (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology. |
J Med Chem |
2017 |
Mejdrova I;Chalupska D;Plackova P;Muller C;Sala M;Klima M;Baumlova A;Hrebabecky H;Prochazkova E;Dejmek M;Strunin D;Weber J;Lee G;Matousova M;Mertlikova-Kaiserova H;Ziebuhr J;Birkus G;Boura E;Nencka R |
View
More |
| 28778471
|
Design, synthesis and evaluation of 2,2-dimethyl-1,3-dioxolane derivatives as human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2017 |
Zhang Q;Cao R;Liu A;Lei S;Li Y;Yang J;Li S;Xiao J |
View
More |
| 29433930
|
Structure-based design and synthesis of macrocyclic human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2018 |
Namoto K;Sirockin F;Sellner H;Wiesmann C;Villard F;Moreau RJ;Valeur E;Paulding SC;Schleeger S;Schipp K;Loup J;Andrews L;Swale R;Robinson M;Farady CJ |
View
More |
| 30153009
|
Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication. |
J Med Chem |
2018 |
Da Costa L;Scheers E;Coluccia A;Casulli A;Roche M;Di Giorgio C;Neyts J;Terme T;Cirilli R;La Regina G;Silvestri R;Mirabelli C;Vanelle P |
View
More |
| 30646829
|
Good and bad molecular fingerprints for human rhinovirus 3C protease inhibition: identification, validation, and application in designing of new inhibitors through Monte Carlo-based QSAR study. |
J Biomol Struct Dyn |
2020 |
Jain S;Amin SA;Adhikari N;Jha T;Gayen S |
View
More |
| 30844608
|
New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: Design, synthesis, anti-HAV effect and molecular modeling. |
Eur J Med Chem |
2019 |
Kassem AF;Batran RZ;Abbas EMH;Elseginy SA;Shaheen MNF;Elmahdy EM |
View
More |
| 31416365
|
Overview of human rhinovirus immunogenic epitopes for rational vaccine design. |
Expert Rev Vaccines |
2019 |
Stepanova E;Isakova-Sivak I;Rudenko L |
View
More |
| 32103448
|
Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design. |
Virol Sin |
2020 |
Yuan S;Fan K;Chen Z;Sun Y;Hou H;Zhu L |
View
More |
| 32568687
|
COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles\' heel conserved region to minimize probability of escape mutations and drug resistance. |
Comput Biol Med |
2020 |
Robson B |
View
More |
| 33356169
|
Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2. |
Bioconjug Chem |
2021 |
Larue RC;Xing E;Kenney AD;Zhang Y;Tuazon JA;Li J;Yount JS;Li PK;Sharma A |
View
More |
| 33872498
|
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2. |
J Med Chem |
2022 |
Dai W;Jochmans D;Xie H;Yang H;Li J;Su H;Chang D;Wang J;Peng J;Zhu L;Nian Y;Hilgenfeld R;Jiang H;Chen K;Zhang L;Xu Y;Neyts J;Liu H |
View
More |
| 37030533
|
Computer-aided drug design in seeking viral capsid modulators. |
Drug Discov Today |
2023 |
Zhao S;Zhang X;da Silva-Junior EF;Zhan P;Liu X |
View
More |
| 7621403
|
Virus receptors: implications for pathogenesis and the design of antiviral agents. |
Clin Microbiol Rev |
1995 |
Norkin LC |
View
More |
| 7820548
|
Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. |
Curr Biol |
1994 |
Grant RA;Hiremath CN;Filman DJ;Syed R;Andries K;Hogle JM |
View
More |
| 7919786
|
Protein structure--based drug design. |
Annu Rev Biophys Biomol Struct |
1994 |
Whittle PJ;Blundell TL |
View
More |
| 7994569
|
Structure-based drug design of antirhinoviral compounds. |
Structure |
1994 |
Giranda VL |
View
More |
| 8380615
|
On the prediction of binding properties of drug molecules by comparative molecular field analysis. |
J Med Chem |
1993 |
Klebe G;Abraham U |
View
More |
| 8383771
|
A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A. |
J Mol Biol |
1993 |
Kim KH;Willingmann P;Gong ZX;Kremer MJ;Chapman MS;Minor I;Oliveira MA;Rossmann MG;Andries K;Diana GD;et al. |
View
More |
| 8397301
|
The use of an algorithmic method for small molecule superimpositions in the design of antiviral agents. |
J Comput Aided Mol Des |
1993 |
Diana G;Jaeger EP;Peterson ML;Treasurywala AM |
View
More |
| 8516662
|
Discovery and development of antipicornaviral agents. |
Scand J Infect Dis Suppl |
1993 |
McKinlay MA |
View
More |
| 9294865
|
Use of the multiple copy simultaneous search (MCSS) method to design a new class of picornavirus capsid binding drugs. |
Proteins |
1997 |
Joseph-McCarthy D;Hogle JM;Karplus M |
View
More |
| 9651162
|
Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication. |
J Med Chem |
1998 |
Kong JS;Venkatraman S;Furness K;Nimkar S;Shepherd TA;Wang QM;Aube J;Hanzlik RP |
View
More |
| 9667969
|
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. |
J Med Chem |
1998 |
Webber SE;Okano K;Little TL;Reich SH;Xin Y;Fuhrman SA;Matthews DA;Love RA;Hendrickson TF;Patick AK;Meador JW 3rd;Ferre RA;Brown EL;Ford CE;Binford SL;Worland ST |
View
More |
| 9667970
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Reich SH;Prins TJ;Marakovits JT;Littlefield ES;Zhou R;Tikhe J;Ford CE;Wallace MB;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;Harr JE;DeLisle DM;Worland ST |
View
More |
| 9667971
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Reich SH;Marakovits JT;Prins TJ;Zhou R;Tikhe J;Littlefield ES;Bleckman TM;Wallace MB;Little TL;Ford CE;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;DeLisle DM;Worland ST |
View
More |
| 9875381
|
Approaches to antiviral chemotherapy for acute respiratory infections. |
Antivir Chem Chemother |
1998 |
Shigeta S |
View
More |
| 9888832
|
2-Amino-3-substituted-6-[(E)-1-phenyl-2-(N-methylcarbamoyl)vinyl]imid azo[1,2-a]pyridines as a novel class of inhibitors of human rhinovirus: stereospecific synthesis and antiviral activity. |
J Med Chem |
1999 |
Hamdouchi C;de Blas J;del Prado M;Gruber J;Heinz BA;Vance L |
View
More |
